Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

Name: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection
Published: 2015
License: Public Domain

Gilead Sciences · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

hepatitis-c

hepatitis c virus infection, hcv genotype 4 (gt-4), hcv, sustained virologic response, direct acting antiviral, combination therapy, gs-7977, gs-5885, ribavirin, sofosbuvir, ledipasvir, hepatitis c

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 875741
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.